Novel immune-nutritional prognostic ratio predicts long-term survival in stage I–III colorectal cancer
Our findings demonstrate that INPR is a simple, accessible, and effective prognostic tool for postoperative risk stratification in stage I-III CRC patients, providing valuable guidance for optimizing individualized treatment strategies.
Authors
- Jun Guan (ORCID: https://orcid.org/0009-0007-0282-8724)
- Xiangyue Zeng
- Boxiang Zhang (ORCID: https://orcid.org/0000-0002-5010-0275)
- Elizabeth Whitmore (ORCID: https://orcid.org/0000-0002-7181-6715)
- Ziyi Zhang (ORCID: https://orcid.org/0000-0002-2175-4931)
- Kuan Wang (ORCID: https://orcid.org/0000-0001-8010-9740)
- Yipeng Pan
- Richard J. Aldridge
- Yi Chen (ORCID: https://orcid.org/0000-0001-6167-8032)
- Zeliang Zhao
- Kejin Li
- Lucy Yue Lau
Institutions
- University of Minnesota (US)
- Massachusetts Department of Public Health (US)
- Harvard University (US)
- Xinjiang Medical University (CN)
- Sir Run Run Shaw Hospital (CN)
- Tumor Hospital of Xinjiang Medical University (CN)
- Xinjiang Institute of Engineering (CN)
- Inner Mongolia People's Hospital (CN)
- Southern Medical University (CN)
- Xinjiang University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-12-18
- DOI
- https://doi.org/10.3389/fonc.2025.1694587
- Citations
- 3
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 3.14
Funders
- Natural Science Foundation of Xinjiang